Study: Worse Survival When Specific Thyroid Cancers Spread to Bone

A large study shows bone complications in thyroid cancer are an indicator of a poor prognosis, suggesting the need for more drug research.

7:00 AM

Author | Rosemary Clandos

When cancer metastasizes, bone unwittingly offers a friendly place for tumor cell growth — only to have its hospitality betrayed by pathologic fractures, spinal cord compression, the need for bone surgery or irradiation and an increased risk of death.

MORE FROM THE LAB: Subscribe to our weekly newsletter

In the largest-known study on bone metastases in thyroid cancer, researchers at the University of Michigan Rogel Cancer Center found that patients with follicular and medullary thyroid cancer had the highest rate of cancer-related bone lesions and fractures and an increased risk of death.

"We know that metastases are bad. But patients in our study who had bone metastases had a worse survival rate compared to patients who had metastases at other distant sites," says Megan Haymart, M.D., assistant professor of medicine at Michigan Medicine and one of the researchers on the study. "This suggests that bone metastases are a uniquely poor prognostic indicator."

But patients with localized or regional thyroid cancer — without metastases — have an excellent prognosis, says Palak Choksi, M.D., assistant professor of medicine at Michigan Medicine and lead author of the study.

The Michigan Medicine study, published in the Journal of Clinical Endocrinology and Metabolism, looked at all forms of thyroid cancer — medullary, follicular, papillary and anaplastic. The study was based on SEER-Medicare data and involved about 30,000 patients, 70 percent of whom were Caucasian women with an average age of 64. The high percentage of women in the study reflects that thyroid cancer is three times more common in women than in men.

"Only about 8 percent of patients in the study had either a bone metastasis or skeletal-related event such as a cancer-related bone fracture," Haymart says.

Helping tailor future treatments

Previous studies that looked mainly at differentiated thyroid cancer and bone metastases had a significantly smaller sample size and were largely from single institutions that enrolled patients with differentiated thyroid cancers.

SEE ALSO: When It's Not Exactly Cancer: Renaming Early Stage Thyroid Tumors

Currently, the data on medications for skeletal metastases in thyroid cancer have been extrapolated largely from breast cancer and other cancers that often metastasize to bone, Choksi says. Little research has focused specifically on the use of medications to treat thyroid cancer with skeletal complications.

"Patients with thyroid cancer have been understudied," Haymart says.

This research will help tailor treatment and management, and it's especially useful for patients with high-risk thyroid cancer (medullary and follicular).

"Now that we have identified that certain thyroid cancers are at a higher risk for skeletal-related events, we can appropriately design studies looking at drugs to see which medication could prevent or effectively treat such complications," Choksi says.

"Through our study, we want other doctors to be aware that there is a higher likelihood of skeletal lesions or fractures in this high-risk population," she says.

The authors acknowledge that the study is limited and that its applicability to younger patients is reduced. "Despite this limitation, our study parallels on a larger scale what other smaller studies have shown in a varied population group," Choksi says.

For high-risk patients, future research is needed to show how to prevent and treat bone metastases. Studies have shown that denosumab and bisphosphonates are beneficial for patients with other cancers of the bone. The researchers suspect these drugs may also benefit patients with thyroid cancer and bone metastases, although additional prospective studies are needed.


More Articles About: Rounds Thyroid Cancer Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Spilled pills next to a stethoscope and pile of cash
Health Lab
Drug pricing program improved prostate cancer treatment adherence
Socially vulnerable patients were more likely to stick with oral medications when treated at a hospital participating in 340B program, suggesting these hospitals may have more resources to help patients.
cancer cell blue yellow
Health Lab
Less chemoradiation is possible for some cancer patients
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.
Animated microscopic image of the glioblastoma's tumor microenvironment
Health Lab
New model of key brain tumor feature could help scientists understand how to develop new treatments
Model shows how oncostreams form and behave in brain tumors – and how to inhibit them
cancer cell blue yellow
Health Lab
Targeted drug shows promising ability in treating rare head and neck cancers
Experts at Rogel Cancer Center develop and study the impact of a new drug for salivary gland cancers
Health care provider with stethoscope holds patient's hand
Health Lab
Combatting prostate cancer stigma
Prostate cancer is highly treatable and over 98% of men survive 10 years if the cancer is diagnosed and treated early.
Provider takes a pulse oximetry reading from a patient's finger
Health Lab
Inaccurate pulse oximeter readings could limit transplants, heart pumps for Black patients with heart failure
Racially biased readings of oxygen levels in the blood using pulse oximeters may further limit opportunities for Black patients with heart failure to receive potentially lifesaving treatments, such as heart pumps and transplants